GLSI vs GOVX

Greenwich LifeSciences, Inc. vs GeoVax Labs, Inc. — Valuation Comparison 2026

GLSI

Pharmaceutical Preparations
Greenwich LifeSciences, Inc.
Quality
4.0
out of 10
Value Trap
Price
$26.18
Last close
Models
6/13
Active
VS

GOVX

Pharmaceutical Preparations
GeoVax Labs, Inc.
Quality
5.1
out of 10
Value Trap
24
SAFE
Price
$2.06
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType GLSI Fair ValueGLSI Upside GOVX Fair ValueGOVX Upside
Bayesian DCF Intrinsic $7.40 -71.7% $0.82 -60.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.58 -97.8% $8.71 +322.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for GLSI vs GOVX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GLSI vs GOVX — Which Stock Is More Undervalued?

GOVX scores higher with a 5.1/10 quality rating vs GLSI's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Greenwich LifeSciences, Inc. (GLSI) and GeoVax Labs, Inc. (GOVX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GLSI currently trades at $26.18 with a QOC of 4.0/10, while GOVX trades at $2.06 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).